Peritoneal tuberculosis after imatinib therapy.


Autoria(s): Senn L.; Kovacsovics T.; Tarr P.E.; Meylan P.
Data(s)

01/02/2009

Identificador

http://serval.unil.ch/?id=serval:BIB_C2958BC219EE

isbn:1538-3679

pmid:19204223

doi:10.1001/archinternmed.2008.581

http://my.unil.ch/serval/document/BIB_C2958BC219EE.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C2958BC219EE9

isiid:000263202600015

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Archives of Internal Medicine, vol. 169, no. 3, pp. 312-313

Palavras-Chave #Adult; Antineoplastic Agents; Antitubercular Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphopenia; Male; Opportunistic Infections; Peritonitis; Peritonitis, Tuberculous; Piperazines; Pyrimidines
Tipo

info:eu-repo/semantics/article

article